IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence()()

Head and neck squamous cell carcinomas (HNSCC) exhibit a small population of uniquely tumorigenic cancer stem cells (CSC) endowed with self-renewal and multipotency. We have recently shown that IL-6 enhances the survival and tumorigenic potential of head and neck cancer stem cells (i.e. ALDH(high)CD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neoplasia
Main Authors: Finkel, Kelsey A., Warner, Kristy A., Kerk, Samuel, Bradford, Carol R., McLean, Scott A., Prince, Mark E., Zhong, Haihong, Hurt, Elaine M., Hollingsworth, Robert E., Wicha, Max S., Tice, David A., Nör, Jacques E.
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press 2016
Assuntos:
Original article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887598/
https://ncbi.nlm.nih.gov/pubmed/27237319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.03.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares